Is BioCryst Pharmaceuticals, Inc. (BCRX) a Buy, Sell, or Hold?
NASDAQ : BCRX
BioCryst Pharmaceuticals, Inc. — Analyst Ratings
$8.98 USD
-$0.26 (-2.81%)
- Volume
- 2.85M
- Average Volume
- 4.9M
- Market Capitalization
- $2.28B
- P/E Ratio
- -5.19
- Dividend Yield
- 0.00%
- Price Target
- $17.00
- Year High
- $11.22
- Year Low
- $6.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.91
Analyst Consensus Summary
Consensus Rating
Sell
29 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-47.2%
vs Current Price
Price Target
$17.00
Average TargetPrice Target Range
Lowest Target
$14.00
-35.9% DOWNSIDE
Average Target
$17.00
Median Estimate
Highest Target
$29.00
-69.0% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 29
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 25 | 4 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Jefferies | Maury Raycroft | $17 | $9.55 | 2026-06-30 04:42 AM | 78.0% |
| JMP Securities | Jonathan Wolleben | $25 | $6.97 | 2025-11-05 05:41 AM | 258.7% |
| Jefferies | Maury Raycroft | $15 | $6.42 | 2025-10-14 03:21 PM | 133.6% |
| Barclays | Gena Wang | $7 | $7.51 | 2024-08-06 01:31 AM | -6.8% |
| Jefferies | Maury Raycroft | $11 | $7.51 | 2024-08-05 12:01 PM | 46.5% |